Nanocapsule formation by nanocrystals

Nanoencapsulation Technologies for the Food and Nutraceutical Industries

Volumn , Issue , 2017, Pages 165-186

  Romero, Gregori B ^a   Brysch, Wolfgang ^b   Keck, Cornelia M ^c   Müller, Rainer H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Athenion GmbH   (Germany)

^c PharmaSol GmbH   (Germany)

Author keywords

Flavonoids; Food; Functional drinks; Nanocrystals; Nanosuspensions; Nutraceuticals; Well being

Indexed keywords

BEVERAGES; BIOCHEMISTRY; FLAVONOIDS; FOOD PRODUCTS; NANOCRYSTALS; SUSPENSIONS (FLUIDS);

BIOACTIVE INGREDIENTS; FUNCTIONAL DRINKS; GASTROINTESTINAL TRACT; NANO-SUSPENSIONS; NUTRACEUTICAL PRODUCTS; NUTRACEUTICALS; ORAL BIOAVAILABILITIES; WELL BEING;

FUNCTIONAL FOOD;

EID: 85054248246     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-809436-5.00006-9     Document Type: Chapter

References (46)

1. Al Shaal L., Shegokar R., Muller R.H. Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation. Int. J. Pharma. 2011, 420:133-140.
2. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharma. Res. 1995, 12:413-420.
3. Auweter, H., Bohn, H., Heger, R., Horn, D., Siegel, B., Siemensmeyer, K., 2002. US Patent 6,494,924. Precipitated water-insoluble colorants in colloid disperse form.
4. Baker G.A., Burnham T.A. The market for genetically modified foods: consumer characteristics and policy implications. Int. Food Agribus. Man. Rev. 2001, 4:351-360.
5. Bangham A.D., Haydon D.A. Ultrastructure of membranes: biomolecular organization. Brit. Med. Bull. 1968, 24:124-126.
6. Bangham A.D., Horne R. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J. Mol. Biol. 1964, 8:660IN2-668IN10.
7. 10 oral bioavailability: effect of formulation type. J. Pharma. Investig. 2013, 43:431-451.
8. Barenholz Y.C. Doxil®-The First FDA-Approved Nano-Drug: From an Idea to a Product 2012, Pan Standford Publishing Pte. Ltd, Singapure, pp. 335-398.
9. Corbo M.R., Bevilacqua A., Petruzzi L., Casanova F.P., Sinigaglia M. Functional beverages: the emerging side of functional foods. Compr. Rev. Food Sci. Food Saf. 2014, 13:1192-1206.
10. Damge C., Vranckx H., Balschmidt P., Couvreur P. Poly (alkyl cyanoacrylate) nanospheres for oral administration of insulin. J. Pharma. Sci. 1997, 86:1403-1409.
11. Diederichs J.E., Muller R.H. Liposome in Kosmetika und Arzeimitteln. Die Pharmazeutische Industrie 1994, 56:267-275.
12. Downing N.S., Ross J.S., Jackevicius C.A., Krumholz H.M. How Abbott's fenofibrate franchise avoided generic competition. Arch. Intern. Med. 2012, 172:724-730.
13. Faridi Esfanjani A.F., Jafari S.M. Biopolymer nano-particles and natural nano-carriers for nano-encapsulation of phenolic compounds. Colloids Surf. B 2016, 146:532-543.
14. Gabizon A., Catane R., Uziely B., Kaufman B., Safra T., Cohen R., Martin F., Huang A., Barenholz Y. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 1994, 54:987-992.
15. Jafari S.M., McClements D.J. Nanotechnology approaches for increasing nutrient bioavailability. Advances in Food and Nutrition Research 2017, Elsevier, New York.
16. Junghanns J.-U., Muller R.H. Nanocrystal technology, drug delivery and clinical applications. Int. J. Nanomed. 2008, 3:295-310.
17. Katouzian I., Jafari S.M. Nano-encapsulation as a promising approach for targeted delivery and controlled release of vitamins. Trends Food Sci. Technol. 2016, 53:34-48.
18. Keck C.M., Muller R.H. Smart crystals-review of the second generation of drug nanocrystals. Nanoparticlulates as drug carriers 2008, Imperial College Press, London. V.P. Torchilin (Ed.).
19. Kipp, J.E., Wong, J.C.T., Doty, M.J., Rebbeck, C.L., 2003. USA Patent Application. Microprecipitation method for preparing submicron suspensions.
20. Lippacher, A., 2000. Pharmaceutical characterisation of liquid and semi-solid SLN dispersions for topical application. PhD-Thesis, Freie Universität Berlin, Berlin.
21. Liversidge G.G., Cundy K.C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharma. 1995, 125:91-97.
22. Liversidge, G.G., Cundy, K.C., Bishop, J., Czekai, D., 1991. US Patent 5,145,684. Surface modified drug nanoparticles.
23. Merisko-Liversidge, E., 2002. Nanocrystals: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds. In: Marty, J.J. (Ed.), Particles. Orlando, Marcel Dekker.
24. Mohammadi A., Jafari S.M., Assadpour E., Faridi Esfanjani A. Nano-encapsulation of olive leaf phenolic compounds through WPC-pectin complexes and evaluating their release rate. Int. J. Biol. Macromolec. 2016, 82:816-822.
25. Mohammadi A., Jafari S.M., Esfanjani A.F., Akhavan S. Application of nano-encapsulated olive leaf extract in controlling the oxidative stability of soybean oil. Food Chem. 2016, 190:513-519.
26. Möschwitzer, J.P., 2005. Method for the production of ultra-fine submicron suspensions. DE1020050117864.
27. Möschwitzer, J., Lemke, A., 2006. Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof.
28. Müller R.H., Junghanns J.-U. Drug nanocrystals/nanosuspensions for the delivery of poorly soluble drugs. Nanoparticulates as Drug Carriers 2006, Imperial College Press, London. first ed. V.P. Torchilin (Ed.).
29. Müller R.H., Keck C.M. Twenty years of drug nanocrystals: where are we, and where do we go?. Eur. J. Pharma. Biopharma. 2012, 80:1-3.
30. Müller, R.H., Möschwitzer, J., 2015. Method and device for producing very fine particles and coating such particles. U.S. Patent No. 9,168,498.
31. Müller, R.H., Becker, R., Kruss, B., Peters, K., 1996. US patent 5,858,410. Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution.
32. Müller, R.H., Becker, R., Kruss, B., Peters, K., 1999. Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution. U.S. Patent No. 5,858,410.
33. Müller R.H., Jacobs C., Kayser O. Nanosuspensions for the formulation of poorly soluble drugs. Pharmaceutical Emulsions and Suspensions 2000, 383-407. Marcel Dekker, New York. F. Nielloud, G. Marti-Mestres (Eds.).
34. Müller R.H., Jacobs C., Kayser O. DissoCubes-a novel formulation for poorly soluble and poorly bioavailable drugs. Modified-release drug delivery systems 2002, 135-149. Marcel Dekker, New York. M.J. Rathbone, J. Hadgraft, M.S. Roberts (Eds.).
35. Müller R.H., Gohla S., Keck C.M. State of the art of nanocrystals-special features, production, nanotoxicology aspects and intracellular delivery. Eur. J. Pharma. Biopharma. 2011, 78:1-9.
36. Müller R.H., Chen R., Keck C.M. Smartcrystals for consumer care & cosmetics: enhanced dermal delivery of poorly soluble plant actives. H and PC Today 2013, 8:18-24.
37. Müller R.H., Zhai X., Romero G.B., Keck C.M. Nanocrystals for passive dermal penetration enhancement. Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement 2016, 283-295. Springer, Berlin, Heidelberg. N. Dragicevic, H.I. Maibach (Eds.).
38. Noyes A., Whitney W. The rate of solution of solid substances in their own solutions. J. Am. Chem. Society 1897, 19:930-934.
39. Pellegrino T., Manna L., Kudera S., Liedl T., Koktysh D., Rogach A.L., Keller S., Rädler J., Natile G., Parak W.J. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: a general route to water soluble nanocrystals. Nano Lett. 2004, 4:703-707.
40. Petersen, R. 2006. Patent WO2008058755. Nanocrystals for use in topical cosmetic formulations and method of production thereof.
41. Ponchel G., Montisci M.-J., Dembri A., Durrer C., Duchene D. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur. J. Pharma. Biopharma. 1997, 44:25-31.
42. Rabinow B.E. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 2004, 3:785-796.
43. Salazar J., Müller R.H., Möschwitzer J.P. Combinative particle size reduction technologies for the production of drug nanocrystals. J. Pharma. 2014, 2014:14.
44. Schubert R. Liposomen in arzneimitteln. Pharmazeutische Technologie: Moderne Arzneiformen 1998, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart. R.H. Muller, G.E. Hildebrand (Eds.).
45. Schumann, R., 1995. Physical stability of parenteral fat emulsions: development of a characterisation procedure with special focus on analytical techniques. PhD-Thesis, Freie Universität Berlin, Berlin.
46. Stieb M. Mechanische Verfahrenstechnik 1 2013, Springer-Verlag, Weblink. Available from: http://www.laprairie.com/default/platinum-collection/cellular-cream-platinum-rare/95790-00153-14.html#start=1&cgid=platinum-collection.